Table 2.
Results of Study Safety Indicators and Study Biomarkers
| Safety Indicators | ||
|---|---|---|
| Variables (n = 53 sessions) | Pre session | Post session |
| HCO3 (mmol/L), median (IQR) | 25.5 (22.3-28.2) | 25.85 (23.8-28.25) |
| Na, (mEq/L), median (IQR) | 138 (135-141) | 136 (134-140) |
| Metabolic Alkalosis, n (%) | 5 (9.4) | |
| Dysnatremia, n (%) | 8 (15.0) | |
| Hypernatremia, n (%) | 1 (1.8) | |
| Biomarkers | ||
| Variables (n = 53 sessions) | Pre session | Post session |
| Ur (mg/dL), median (IQR) | 107 (59-166) | 114 (66-162) |
| iCa* (mg/dL), median (IQR) | 4.39 (4.1-4.71) | 4.56 (4.04-4.9) |
| K (mEq/L), median (IQR) | 4.3 (3.6-4.8) | 4.3 (3.6-4.9) |
| Hb (g/dL), median (IQR) | 7.9 (6.8-9.2) | 8.05 (6.9-8.7) |
* Data observed in 15 of the 53 sessions
Cr, creatinine; Ur, urea; Na, sodium; HCO3, bicarbonate; iCa, ionic calcium; K, potassium; Hb, hemoglobin; IQR, interquartile range. Note: Sample number = 49 patients, 53 sessions